Trxade Health Inc (NAS:MEDS)
$ 9.1 -0.1 (-1.09%) Market Cap: 12.80 Mil Enterprise Value: 19.89 Mil PE Ratio: 0 PB Ratio: 15.17 GF Score: 43/100

Q1 2021 Trxade Group Inc Earnings Call Transcript

Apr 26, 2021 / 09:00PM GMT
Release Date Price: $73.05 (+3.18%)
Operator

Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to Trxade Group's First Quarter 2021 Earnings Conference Call. (Operator Instructions) The earnings press release accompanying this conference call was issued at the close of market today. The quarterly report, which includes the company's results for operations for the quarter ending March 31, 2021, was filed with the SEC today.

On our call today is Trxade Group's Founder, Chairman and Chief Executive Officer, Suren Ajjarapu; and Howard Doss, its Chief Financial Officer. The replay of this call and webcast will be available for the next 30 days on the company's website under the NASDAQ MEDS link. The company website also includes more supporting industry information.

At this time, I'd like to turn the call over to Howard Doss, the company's Chief Financial Officer. Howard, the floor is yours.

Howard A. Doss
Trxade Group, Inc. - CFO

Thank you, operator, and thank you for joining us today. I'd like to welcome you to our first quarter 2021 financial results conference

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot